Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B9cc887b39f0df8e484b8e1a01ea815d7> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B9cc887b39f0df8e484b8e1a01ea815d7 NCIT_P378 "NCI" @default.
- B9cc887b39f0df8e484b8e1a01ea815d7 type Axiom @default.
- B9cc887b39f0df8e484b8e1a01ea815d7 annotatedProperty IAO_0000115 @default.
- B9cc887b39f0df8e484b8e1a01ea815d7 annotatedSource NCIT_C176568 @default.
- B9cc887b39f0df8e484b8e1a01ea815d7 annotatedTarget "A preparation of autologous human T-lymphocytes that are genetically engineered to express a chimeric antigen receptor (CAR) targeting the tumor-associated antigen (TAA) CD22, with potential immunostimulating and antineoplastic activities. Upon administration, the autologous anti-CD22 CAR-expressing T-cells SCRI-CAR22v2 express anti-CD22-CAR on their cell surfaces and bind to the CD22 antigen on tumor cell surfaces leading to lysis of CD22-expressing B-cells. CD22, a B-lineage-restricted, transmembrane phosphoglycoprotein, is expressed on malignant B-cells." @default.